India Exchange Filings

Gujarat Themis Biosyn Q2 FY27 Earnings and Board Highlights

Gujarat Themis Biosyn Ltd approves Q2 FY27 results, reporting ₹8.47 crore standalone profit and ₹13.84 crore consolidated loss

  • Standalone revenue was ₹47.46 crore (+12.1% YoY); net profit fell 40.6% YoY, with a 37.4% EBITDA margin.
  • Consolidated revenue was ₹49.92 crore (+17.9% YoY); results included a ₹1.17 crore earthquake-related subsidiary loss.
  • Company Secretary and Compliance Officer Vineet Gawankar will resign effective 30 November 2026.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.